Pronota raises an additional EUR 1.5 million in a final close of its Series B financing totaling EUR 7.9 million
19-May-2010
- Belgium
The results obtained so far in its cardio-renal and other programs provide validation of Pronota's technology. Pronota now addresses a range of significant commercial opportunities, and is aiming to have its first product ready for launch in 2012.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.